| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000027044 |
| Receipt No. | R000031005 |
| Official scientific title of the study | Development study on kelp liquid therapy for dry mouth |
| Date of disclosure of the study information | 2017/04/18 |
| Last modified on | 2017/04/18 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Development study on kelp liquid therapy for dry mouth | |
| Title of the study (Brief title) | Development study on kelp liquid therapy for dry mouth | |
| Region |
|
|
| Condition | ||
| Condition | Dry mouth | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Efficacy of kelp liquid therapy for dry mouth. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Salivary secretion |
| Key secondary outcomes | Oral sensory questionnaire |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | water gargle | |
| Interventions/Control_2 | kelp liquid gargle | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1)Patients who diagnosed with dry mouth at Division of Oral Diagnosis, Tohoku University.
(2)Patients aged tewnty or over at the regsitration who consent the participation of this study. (3)Patients accepted regardless of Gender or severity of dry mouth or medication. |
|||
| Key exclusion criteria | (1)Patients with oral cancer.
(2)Patients under the cancer therapy(Chemotherapy, radiotherapy, molecular target therapy, etc.) or with history of cancer. (3)Patients who received kelp liquid therapy. (4) Patients who have allergie or hypersensitivity to kelp or kelp broth. (5)Patients with contraindications of iodine (thyroid gland disease, phthisis, Dermatitis Herpetiformis Duhring, etc. ). (6)Patients with seviere herpetic, lichenious or ulcerative oral mucosal disease. (7)Patients who are difficult to give their informed consent in writing. (8)Patients who can not tolerate oral dryness test (measurement of whole salivary secretion, measurement of minor salivary secretion, mouth moisture retention measurement) (9)Patients who are consider to be inappropriate by the trial investigatiors. |
|||
| Target sample size | 220 | |||
| Research contact person | |
| Name of lead principal investigator | Shizuko, Satoh |
| Organization | Tohoku University
|
| Division name | Division of Oral Diagnosis |
| Address | 4-1 Seiryo-machi, Aoba-ku, Sendai, Japan |
| TEL | 022-717-8390 |
| kuri-shu@dent.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Shizuko, Satoh |
| Organization | Tohoku University |
| Division name | Division of Oral Diagnosis |
| Address | 4-1 Seiryo-machi, Aoba-ku, Sendai, Japan |
| TEL | 022-717-8390 |
| Homepage URL | |
| kuri-shu@dent.tohoku.ac.jp | |
| Sponsor | |
| Institute | Tohoku University
Division of Oral Diagnosis |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Science and Technology Agency
|
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | Ajinomoto Co., Inc,.
|
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031005 |